Worldwide Problem: Doctors Still Leave Medical School Without Knowing About the Endocannabinoid System
Can Europe scale up to 5 million medical cannabis patients? That was one of the main discussion points at the recent Cannabis Europa Conference in London (pictured above) which found the medical cannabis industry in Europe is thriving but science and medical training is lagging far behind.
Rise in Medical Cannabis Patients Poses New Challenges for Employers
Cannabis in the workplace will increasingly become an issue with the rising number of medical cannabis patients in South Africa. One of the potential dilemmas is the balancing the rights of an employee to privacy around their ailments and medication against the obligations of the employer to provide a safe working environment for all workers.
SAHPRA Refining Cannabis Regulations in Light of Evolving Landscape
SAHPRA says its refining its regulatory framework as the South African cannabis landscape evolves. That’s according to its 2025/26 Performance Plan (undated) in which it wants to improve its systems and technology, address patient access issues and regulate product standardization..
Dr Shiksha Gallow: Taking SA Cannabis Research to the World Stage
South Africa’s ‘medical cannabis ambassador’, Dr. Shiksha Gallow, is on fire — and the world is taking notice. From Puerto Rico to Costa Rica, Australia to Italy, this East London trailblazer is rewriting the narrative of cannabis in medicine and putting Mzansi’s research firmly on the global stage.
Australia Clamps Down on Medical Cannabis After 1 Doctor Exposed for Issuing Over 17 000 Prescriptions in Just 6 Months!
Australia’s health regulators have announced new official guidelines for medical cannabis prescriptions following widespread abuse of the system. It’s been revealed that some practitioners have issued over 10 000 prescriptions in just six months.
Dr Glenda Gray Appointed to SAHPRA as Member of New Board Headed by Dr Thapelo Motshudi
The Minister of Health has appointed a new board for the South African Health Products Regulatory Authority with Dr Thapelo Motshudi becoming the new chair and Dr Glenda Gray (both pictured here) as his vice. CEO Dr Boitumelo Semete-Makokotlela remains in her position.
TUT Takes Plant Medicine to New Level, Sees Cannabis as a Catalyst for Health Innovation
The Tshwane University of Technology is spearheading breakthrough research on unlocking the value of plant medicine. It has honed in on four product streams for R&D – neutraceuticals, traditional medicine, mushroom cultivation and probiotics, with a view to developing community-based businesses.
Cannabis at the Crossroads: Lessons from the UK for South Africa’s Medical Cannabis Future
The release of the UK Medical Cannabis White Paper 2025 marks a pivotal moment in global cannabis policy, showcasing how evidence-based regulation, private-sector innovation, and patient-centred demand can create a thriving medical cannabis economy valued at over £300 million. In contrast, South Africa’s medical cannabis sector remains mired in regulatory inefficiencies, policy delays, and a lack of infrastructure, despite our immense potential as a global leader in cannabis production.
Cannabis and Psychedelics Rated Highly as Treatments for Eating Disorders
The American Medical Association studied a wide range of drugs to research their effects on alleviating symptoms of eating disorder. Cannabis and psychedelics were the most ‘highly rated’ of a small class of drugs found to be effective in this sphere.
European Medical Cannabis Sector Experiencing ‘Unprecedented Growth’
Europe’s medical cannabis landscape has undergone a decade of immense change and is growing like never before. The market is expanding rapidly, driven by progressive legislation, expanding patient access and a maturing supply chain.